| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Methyl dodonate A; Methyl dodonate A | CFN97754 | 349534-70-9 | C21H28O4 = 344.45 | 5mg | QQ客服：1413575084 |
| 1-乙酸基-5-去乙酰基-巴卡亭 I; 1-Acetoxy-5-deacetylbaccatin I | CFN90307 | N/A | C32H44O14 = 652.7 | 5mg | QQ客服：3257982914 |
| Methyl dodonate A acetate; Methyl dodonate A acetate | CFN97755 | 349487-98-5 | C23H30O5 = 386.49 | 5mg | QQ客服：3257982914 |
| 丹参新醌A; Danshenxinkun A | CFN90325 | 65907-75-7 | C18H16O4 = 296.32 | 5mg | QQ客服：215959384 |
| 丹参新醌B; Danshenxinkun B | CFN90326 | 65907-76-8 | C18H16O3 = 280.3 | 5mg | QQ客服：215959384 |
| 丹参新醌C; Danshenxinkun C | CFN90327 | 65907-77-9 | C16H12O3 = 252.3 | 5mg | QQ客服：215959384 |
| 紫杉醇; Paclitaxel | CFN97759 | 33069-62-4 | C47H51NO14 = 853.92 | 20mg | QQ客服：2056216494 |
| 丹参新醌D; Danshenxinkun D | CFN90328 | 98873-76-8 | C21H20O4 = 336.38 | 5mg | QQ客服：2056216494 |
| 1,2-二氢丹参醌; 1,2-Dihydrotanshinquinone | CFN90333 | 77769-21-2 | C18H14O3 = 278.3 | 5mg | QQ客服：2056216494 |
| 新穿心莲内酯; Neoandrographolide | CFN97766 | 27215-14-1 | C26H40O8 = 480.60 | 20mg | QQ客服：2159513211 |
| 3-羟基亚甲基丹参醌; 3-Hydroxymethylenetanshinquinone | CFN90348 | 83145-47-5 | C18H14O4 = 294.30 | 5mg | QQ客服：3257982914 |
| 3alpha-羟基丹参酮IIA; 3alpha-Hydroxytanshinone IIA | CFN90352 | 97399-71-8 | C19H18O4 = 310.35 | 5mg | QQ客服：1457312923 |
| 羟基丹参酮IIA; Hydroxytanshinone IIA | CFN90353 | 18887-18-8 | C19H18O4 = 310.35 | 5mg | QQ客服：1413575084 |
| 异隐丹参酮; Isocryptotanshinone | CFN90355 | 22550-15-8 | C19H20O3 = 296.36 | 5mg | QQ客服：215959384 |
| 异丹参酮I; Isotanshinone I | CFN90356 | 20958-17-2 | C18H12O3 = 276.29 | 5mg | QQ客服：215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)